Therefore, the areas listed as protection and surveillance zones in France, currently set out in Annex I to Implementing Decision (EU) 2025/1708, should be amended both spatially and temporally, in order to prevent the further spread of infection with lumpy skin disease virus in France and to the rest of the Union. Accordingly, it is necessary to amend the list of restricted zones, and the duration of the measures to be applied therein, set out in Annex I to that Implementing Decision.
Recital 5, Decision_act (EU) 2026/68
In forcesince 23 Dec 2025